Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

Instead of injections, they are investigating whether a common skin bacterium, Staphylococcus epidermidis, could deliver vaccines through a simple topical cream. The discovery challenges long-held ...